ABSTRACT
INTRODUCTION
Obesity is an epidemic associated with high perinatal mortality and morbidity 1, 2 . In the developed world, the prevalence of obesity is reaching unprecedented levels. In 2013, 19% of women of childbearing age in the UK were obese, a significant increase from the reported prevalence of 12% in 1993 3 . There is a considerable body of evidence that links maternal obesity to a higher risk of adverse pregnancy outcome, including hypertensive disorders of pregnancy, diabetes, pregnancy loss, intrapartum complications and maternal death 2, [4] [5] [6] .
Normal physiological adaptation to pregnancy includes an increase in heart rate (HR) and cardiac output (CO) and a decrease in mean arterial pressure (MAP) and systemic vascular resistance (SVR). Structurally, there is significant cardiac remodeling, with an increase in left ventricular wall mass and chamber size 7 . Maternal obesity is associated with increased sympathetic activation, resulting in an increase in HR, myocardial contractility and vasoconstriction, which in turn lead to a raised MAP and SVR. Endothelial cell dysfunction caused by the release of pro-inflammatory mediators by adipose tissue is a contributory factor to the cardiovascular complications associated with obesity.
Despite the significant health and economic impact of maternal obesity, there is a paucity of good-quality studies assessing central hemodynamic parameters in morbidly obese pregnant women. The results of published studies are conflicting, with most including small sample sizes 8, 9 . One reason for this is the limited availability of validated, non-invasive tools that can be employed reliably and safely to investigate maternal hemodynamics. Using invasive methods, such as thermodilution via a pulmonary artery catheter, would be neither ethical nor practically feasible in an obstetric population. The majority of published data on maternal hemodynamics in morbidly obese women have been obtained by echocardiography, which is regarded as the widely accepted, non-invasive method of choice in the obstetric population. The main aim of this study was to investigate maternal hemodynamics in morbidly obese women.
METHODS

Study population and recruitment
This was a prospective, case-control study of 30 morbidly obese pregnant women and 327 controls. Obesity is defined as a body mass index (BMI) ≥ 30 kg/m 2 and is subdivided into class I (BMI 30-34.9 kg/m 2 ), class II (BMI 35-39.9 kg/m 2 ) and class III (BMI ≥ 40 kg/m 2 ) 1,2,6,7 . Morbid obesity is defined as BMI ≥ 40 kg/m 2 1,2,7 . The control population was matched for maternal age and gestational age and had a BMI between 20 and 29.9 kg/m 2 . We intended to recruit 10 controls for each obese case (ratio 1:10). Women aged 16 years and over with a singleton pregnancy in the second or third trimester were recruited from routine antenatal scanning clinics and the maternity day assessment unit at our tertiary center. Women who were found to be hypertensive at the time of study recruitment, had a pre-existing diagnosis of hypertensive disorders of pregnancy (as defined by the International Society for the Study of Hypertension in Pregnancy 10 ) or congenital/acquired heart disease were excluded from the study. Written consent was obtained from all study participants and research ethics committee approval (12/LO/0810) was obtained prior to study commencement.
Research investigations
All non-invasive assessments were performed in the same room, under standardized conditions for the entire cohort. Maternal height, weight and blood pressure (BP) were obtained at study recruitment prior to hemodynamic assessment; maternal BMI was calculated. BP was obtained with an upper-arm automatic BP monitor (Microlife, Microlife AG Swiss Corporation, Switzerland) with the woman in a semi-recumbent position and using an appropriate cuff size. Following a 5-min period of physical inactivity, during which a medical history was obtained, CO measurements were obtained using a USCOM-1A ® (ultrasound CO monitor, USCOM, NSW, Australia) device. Measurements were obtained on one occasion for each subject. Subjects in the early second trimester (before 20 weeks' gestation) were assessed in a supine position, whereas those in the late second (after 20 weeks' gestation) and third trimesters were assessed in a left lateral position.
USCOM-1A utilizes continuous wave Doppler with a non-imaging probe placed at the suprasternal notch to obtain velocity time integrals (VTIs) of transaortic blood flow at the left ventricular outflow tract. Using an anthropometric algorithm, which correlates the outflow tract diameter with the patient's height, USCOM-1A uses the VTIs to compute stroke volume (SV) and, therefore, CO and produces a complete hemodynamic profile, including HR, SV, CO and SVR. By calculating the body surface area (BSA) using the patient's weight and height, USCOM-1A calculates the indexed hemodynamic variable corrected for BSA. The parameters examined included cardiac index (CI), SV index (SVI) and SVR index (SVRI).
USCOM-1A measurements were performed in the flow tracer mode (automated tracing of each Doppler profile). For each patient, one Doppler acquisition containing a minimum of two Doppler profiles (cardiac cycles) was used for analysis. One investigator assessed the quality of each Doppler acquisition prior to analysis. Doppler profiles were excluded if deemed to be unsuitable for analysis (e.g. noise artifact from valve closure). Acquisitions with the least amount of interference and the best quality VTIs, deemed by the study investigator to best represent transaortic blood flow, were included. All researchers received formal training on the correct use of the USCOM-1A device and performed a minimum number of training cases prior to study recruitment.
Statistical analysis
Categorical data were presented as n (%) and continuous data as median (interquartile range). Continuous data were examined using the Shapiro-Wilk test to assess their distribution. The chi-square test or Fisher's exact test was used to compare categorical variables, as appropriate. The Mann-Whitney U-test was used to compare the medians of the hemodynamic variables between the two groups. P < 0.05 was deemed statistically significant. All statistical analyses were carried out using IBM SPSS Statistics version 21 (IBM Corporation, Armonk, NY, USA).
RESULTS
In total, 30 women with Class III maternal obesity were recruited into the study. Seven patients were excluded due to hypertensive disorders of pregnancy (n = 5) and poor quality of USCOM-1A Doppler acquisitions (n = 2). Therefore, 23 cases were included in the final analysis. The control group consisted of 327 women. Patients were recruited between September 2012 and April 2016. The median gestational age at study recruitment was 31 weeks for both groups. Baseline demographic characteristics and pregnancy outcomes of both groups are displayed in Table 1 . A summary of the analysis of the hemodynamic variables is shown in Table 2 .
There was no difference in maternal age (P = 0.506) or gestational age at recruitment (P = 0.693) between the groups. There was a significant difference in the proportion of Afro-Caribbean and Caucasian patients between the obese and control groups, with a lower percentage of Caucasian and a higher percentage of Afro-Caribbean women included in the morbidly obese group. Although differences in hemodynamic parameters between the study groups may be attributed to ethnicity, we have shown previously in a much larger prospective study that ethnicity does not affect maternal hemodynamic parameters 11 . MAP was significantly higher in the obese group compared with the control group, both at booking (90 vs 80 mmHg, P < 0.001) and at study recruitment (91 vs 85 mmHg, P < 0.001). As expected, compared with the controls, in the obese group, weight (113 vs 70 kg, P < 0.001) and BMI (41.3 vs 25.9 kg/m 2 , P < 0.001) at the time of assessment were also significantly higher.
Hemodynamic parameters
BSA was, unsurprisingly, significantly higher in the obese group compared with controls (2.36 vs 1.82 m 2 ; Data are given as n (%) or median (interquartile range). *Delivery data available for 317 controls. P < 0.001). HR was also higher in the obese group (P = 0.003). No significant difference was found between the two groups with respect to SV (P = 0.271), CO (P = 0.238) or SVR (P = 0.635). Following correction of the variables for BSA, SVI and CI were shown to be significantly reduced in the obese group when compared with the control group (both P < 0.001; Table 2 , Figures 1  and 2 ). SVRI was higher in the obese group (P < 0.001; Table 2, Figure 3 ).
DISCUSSION
Summary of study findings
Morbidly obese pregnant women had a significantly higher HR, but there was no difference in SV, CO or SVR when compared with the control group. Importantly, once corrected for BSA, we found that morbidly obese pregnant women had a significantly lower SVI and CI than the control group. We also demonstrated that the obese group had a significantly higher SVRI than the control group.
Interpretation of study findings and comparison with the literature
Our data suggest an impaired cardiac function in morbidly obese pregnant women when compared with non-obese controls. Our work also highlights the importance of correcting for BSA when comparing subjects with a wide range of body shapes and sizes, as is standard practice in pediatric cardiology.
Dennis et al. 9 used transthoracic echocardiography to assess cardiovascular changes in a sample of 15 obese women (BMI > 30 kg/m 2 ); when compared with a cohort of 40 women with normal BMI, the authors reported no difference in HR, SV, SVR or CO. However, they did report an increased left ventricular mass in the obese group. Interestingly, the hemodynamic parameters were not corrected for BSA in this study. Previous work by Veille and Hanson 8 investigated eight morbidly obese pregnant women using M-mode echocardiography, but showed no difference in CO or left ventricular function compared with controls. In agreement with other studies 12, 13 we found a significantly higher MAP and HR in our obese group.
Due to increasing interest in non-invasive CO monitoring technology there have been many advances in different modalities within this field. Several non-invasive monitors are commercially available, using various techniques such as ultrasound, bioimpedance and bioreactance. Our group has shown that measurements obtained using USCOM-1A are reproducible and repeatable 14 . When assessed against a standard of two-dimensional transthoracic echocardiography, USCOM-1A meets the critical level of a 30% mean percentage difference between two CO methodologies in the third trimester of pregnancy. Our previous work highlights that USCOM-1A can be used as a clinically acceptable alternative to echocardiography in advanced pregnancy. Its benefits include ease in obtaining a hemodynamic profile as compared with conventional echocardiography.
Study strengths and limitations
The strengths of this study include its novel data, relatively large sample size when compared with other published studies and the exclusion of patients who developed adverse pregnancy outcomes, eliminating the independent bias of these factors on maternal hemodynamics. A limitation of this study was that a non-pregnant morbidly obese group was not included. This group could have provided data on the cardiac function in obese women outside of pregnancy and, therefore, would have allowed us to evaluate whether cardiac impairment occurs independently of, or as a result of, pregnancy.
Clinical and research implications
Our work suggests that cardiac function is altered in morbidly obese pregnant women. We highlight the need to index hemodynamic variables for BSA in order to make appropriate comparisons between individuals with a diverse range of anthropometric parameters. Our data demonstrate that obese pregnant women exhibit an adverse cardiovascular profile, which supports that obesity is a risk factor for maternal cardiovascular disorders 15, 16 . We believe that the increasing prevalence of maternal obesity is a sufficient cause for concern to warrant the attention of future research. The current study, while suggesting an impaired cardiac function, is unable to elucidate structural or functional differences. A reduced CI in maternal obesity could be attributable to a number of pathways, including diastolic or systolic dysfunction or hypertrophic changes 16, 17 . These changes could be assessed using echocardiography. Future work should aim to assess whether cardiac impairment is related to the amount of weight gained and, therefore, the added demand on the cardiovascular system during pregnancy. Moreover, prospective large studies are needed to determine whether cardiac impairment predates pregnancy or occurs as a result of the cardiovascular maladaptation to the significant demands of an ongoing pregnancy. In order to address these important questions, longitudinal assessment is required, both prepregnancy and in obese non-pregnant women.
Conclusion
Our results demonstrate a reduced SVI and CI and a higher SVRI in morbidly obese pregnant women.
Assessing absolute values without correcting for BSA does not allow for appropriate comparison in an obstetric population, especially in the context of obesity. The methodology used in this study has been validated previously and appears to have many positive features enabling its use in future clinical and research work. The novel finding of a reduced CI in morbidly obese pregnant women may explain the predisposition to pre-eclampsia and other adverse outcomes in this population [15] [16] [17] . As impaired maternal hemodynamics in morbid obesity may not necessarily correlate with cardiac dysfunction, further investigation using alternative methodologies is warranted, to carry out an in-depth assessment of structural and functional changes associated with maternal obesity.
